ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Events

Grayscale joins Bitwise in filing to launch a standalone Aave product in the US, betting that Wall Street has retained its appetite for altcoins.Crypto asset managerGrayscale joins Bitwise in filing to launch a standalone Aave product in the US, betting that Wall Street has retained its appetite for altcoins.Crypto asset manager

Grayscale seeks to convert Aave trust into ETF on NYSE Arca

Author: Coinstats

Source: Coinstats

2026/02/16 10:44

1 min read

AAVE$126.94-3.41%

TRUST$0.07701-6.73%

1$0.0006958+0.31%

Grayscale joins Bitwise in filing to launch a standalone Aave product in the US, betting that Wall Street has retained its appetite for altcoins.

Crypto asset manager Grayscale filed for regulatory approval to convert its trust tracking the token of the decentralized lending protocol Aave into an exchange-traded fund (ETF).

Grayscale seeks to convert Aave trust into ETF on NYSE Arca

The company filed a Form S-1 registration statement with the Securities and Exchange Commission on Friday, saying it intends to convert the trust and rename it the Grayscale Aave Trust ETF.

Grayscale added that it is looking to launch the fund on NYSE Arca, one of the most popular exchanges for trading ETFs, under the ticker “GAVE.” It will have a fee of 2.5%, and Coinbase will serve as both its custodian and prime broker.

Market Opportunity

AaveToken Price(AAVE)

$126.94

$126.94$126.94

+0.27%

USD

AaveToken (AAVE) Live Price Chart

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.